Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an announcement.
WuXi AppTec Co., Ltd. has announced the composition of its board of directors and their respective roles, highlighting a diverse mix of executive, non-executive, and independent directors. The announcement also details the structure of four key board committees, indicating a strategic focus on audit, remuneration, strategy, and nomination, which may enhance corporate governance and operational efficiency.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. It provides a broad range of services including research, development, and manufacturing solutions for the pharmaceutical, biotechnology, and medical device industries.
Average Trading Volume: 7,395,828
Technical Sentiment Signal: Buy
Current Market Cap: HK$304.5B
See more data about 2359 stock on TipRanks’ Stock Analysis page.